Fig. 1From: Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancerAssociation of S100A11 gene expression with the survival and clinical features of gastric cancer patients. The survival analysis of S100A11 (probe_ID: 200660_at) was conducted on the KMPlot (https://kmplot.com). a Overall survival (OS). b Post progression survival (PPS). c First progress survival (FP). The association of S100A11 and the clinicopathological features of GC was analysed using the TCGA data. d Tumour vs normal. e Metastasis status. M0: no metastasis; M1: with metastasis. Mx: unknown metastasis status. f Lymph node metastasis stages. g Tumour stages. h Gender. The difference between the two groups was analysed using the Wilcoxon test, while the Kruskal–Wallis test was used to compare the difference among multiple groupsBack to article page